GILD Gilead Sciences, Inc.
76,457
$65.46
$0.08
(0.12%)
| Watchers | 76,457 |
| 52-Wk Low | $64.33 |
| 52-Wk High | $87.87 |
| Market Cap | $81.73B |
| Volume | 815.00 |
| 52-Wk High | $87.87 |
| 52-Wk Low | $64.33 |
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024Business Wire • about 21 hours ago
Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will present 18 abstracts during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. These data showcase the ongoing...
Share to Feed
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities Health Care Conference on Tuesday, May 14 at 11:20am...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy...
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2024 results of operations. Gilead delivered another strong quarter of revenue growth in the first quarter with 6...
Key Events This Week: PCE, GDP, Fed Blackout And Earnings Gallore
Hot on the heels of last week's tech and momentum rout, shaken traders will have to wait until Friday for the main...
Latest Ratings for GILD
DateFirmActionFromTo Mar 2022BarclaysMaintainsUnderweight Mar 2022RBC CapitalMaintainsOutperform Feb 2022BMO CapitalDowngradesOutperformMarket Perform
View More Analyst...
Biotech Innovations Paving the Way in Breast Cancer Fight Biotech Innovations Paving the Way in Breast Cancer Fight PR Newswire VANCOUVER, BC, April 11, 2024 FN Media Group Presents USA News Group...